Price $66.06 |
Market Cap
8.28B
|
Sector Health Care |
Div. Growth
11.10%
|
|
P/E
27.2
|
P/B
7.01
|
P/S
3.06
|
Dividend %
0.30%
|
|
P/CF
-
|
P/FCF
50.8
|
Op. Cash Flow
341.5K
|
FCF
1.1
|
|
Op. Margin
16.10%
|
Net Margin
11.30%
|
ROE
28.60%
|
ROI
13.60%
|
|
ROA
8.80%
|
EPS Growth
19.30%
|
Current Ratio
2.3
|
Debt/Equity
107.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bimi International Medical Inc (BIMI) | $1.99 | - | - | 6.4M | Strong Buy |
| Evogene Ltd (EVGN) | $0.69 | - | - | 22.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.34 | - | - | 14.8M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $21.64 | - | - | 1.19B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.09 | - | - | 4.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
